Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 3]
Phase 3 trial evaluating total-body irradiation with or without fludarabine phosphate followed by donor stem cell transplant in hematologic …
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML) [Phase 1]
A Phase I clinical trial in Chinese patients with acute myeloid leukemia evaluating cafusertib hydrochloride in combination with low-dose cy…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: BI 2536 Infusional Treatment in Patients Over 60 Years of Age With Refractory or Relapsed Acute Myeloid Leukaemia [Phase 2]
Phase 2 trial of BI 2536 infusional treatment in patients over 60 with refractory or relapsed acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood [Phase 1, Phase 2]
Phase 1/2 trial evaluating Wilms' Tumor 1 protein vaccine for blood cancers has completed. Results were posted on 2014-05-08.
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML) [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating induction, consolidation, and intensification therapy for patients younger than 66 with prev…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating cyclophosphamide plus topotecan in patients with refractory or r…
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia [Phase 2]
This is a completed Phase 2 study of Iressa (gefitinib) in patients with relapsed or refractory acute myeloid leukemia. The trial status is …
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 trial evaluating obatoclax mesylate in combination with vincristine, doxorubicin, and dexrazoxane in pediatric patients with relapse…
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Natural Killer Index From Hematopoietic Stem Cell Graft [NA]
Clinical trial update on the natural killer index derived from hematopoietic stem cell graft. The study is listed as completed and includes …
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia [Phase 1]
Phase 1 study of MK-2206 in pediatric patients with recurrent or refractory solid tumors or leukemias has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors [Phase 1]
Phase 1 pilot study evaluating donor-derived natural killer cell infusions for refractory non-B lineage hematologic cancers and solid tumors…
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial evaluating dasatinib in patients with core-binding factor acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: 3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia [Phase 4]
Phase 4 clinical trial evaluating three anthracyclines with two consolidation strategies using different cytarabine (ARA-C) doses and mainte…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Clofarabine and Low-dose Cytarabine Followed by Consolidation Therapy in AML Patients Age Greater Than or Equal to 60 Years [Phase 2]
A Phase 2 study of Clofarabine and low-dose Cytarabine followed by consolidation in patients with acute myeloid leukemia aged 60 and older h…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute Leukemia [Phase 1]
Phase 1 study of AMD3100 (plerixafor) as a sensitizing agent in allogeneic blood or marrow transplant for chemotherapy-resistant pediatric a…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer [NA]
This clinical-trial update reports completion and results posting for palifermin used to prevent chronic graft-versus-host disease in patien…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old [Phase 3]
Phase 3 trial evaluating adding Lomustine to chemotherapy and allogeneic transplantation in older adults with acute myeloid leukemia; the st…
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial evaluating T-cell depleted allogeneic stem cell transplantation for hematologic malignancies; study is completed with…
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients [Phase 2, Phase 3]
Phase 2/3 trial evaluating AZD1152 alone and with low-dose cytosine arabinoside in acute myeloid leukemia has completed with posted results …
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant [Phase 1]
Phase 1 trial evaluating vaccine therapy with or without donor lymphocyte infusion in patients with acute myeloid leukemia, acute lymphoblas…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia [Phase 2]
Phase II study of clofarabine in adults with refractory or relapsed acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML) [Phase 1]
This is a Phase 1 clinical trial of clofarabine in Japanese patients with acute myeloid leukemia. The study has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy [Phase 1]
A National Cancer Institute-sponsored Phase 1 trial evaluating sunitinib malate in HIV-positive cancer patients on antiretroviral therapy ha…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: A Safety and Tolerability Extension Trial Assessing Repeated Dosing of Anti-KIR (1-7F9) Human Monoclonal Antibody in Patients With Acute Myeloid Leukaemia [Phase 1]
This clinical-trial update describes a Phase 1 safety and tolerability extension study of repeated dosing with an anti-KIR monoclonal antibo…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia [Phase 2]
Phase 2 trial evaluating gemcitabine in children with relapsed or refractory acute lymphoblastic leukemia or acute myeloid leukemia has comp…